Guidance

Unavailability of intravesical BCG for treatment of bladder cancer

Information and sources of further guidance relating to the current shortage of products used in the treatment of some bladder cancers

Applies to England

Documents

Letter on unavailability of intravesical BCG for treatment of bladder cancer

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

A letter from Professor Sir Mike Richards, National Clinical Director for Cancer

Updates to this page

Published 9 July 2012

Sign up for emails or print this page